-
CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
-
High-Performance Novel HAT Cell Line for Gene Therapy, Published in Molecular Therapy Methods & Clinical Development, and Ready for Commercial Use
-
CHITOSE’s AI Doubles Protein Productivity in Filamentous Fungi Compared to Best Human-Designed Conditions
-
Paper on Novel CHO-MK Cell Line Receives 2025 Excellent Paper Award from the Society of Biotechnology, Japan
-
CHITOSE Group Forms Capital and Business Alliance with TOPPAN Holdings
-
MYCENAX and Chitose Laboratory Corp. to Scale-Up Production and Strengthen Marketing Activities for CHO-MK Cells
